-
Posted by
Two Blokes Jul 20 -
Filed in
Stock
-
1 view
Merck (MRK -1.91%), a leading pharmaceutical company, generates consistent revenue and profits. However, the stock has been under pressure over the past year due to its reliance on Keytruda, its famous cancer medicine.
